Intersect ENT Reports First Quarter 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Intersect ENT Reports First Quarter 2017 Results

Intersect ENT (XENT) PT Raised to $22 at Northland Capital Markets; Medicare Cuts Not Hurting

May 3, 2017 12:25 PM EDT

Northland Capital Markets raised its price target on Intersect ENT (NASDAQ: XENT) to $22.00 (from $17.00) while maintaining a Outperform rating. The firm also raised FY18 numbers.

Analyst Suraj Kalia notes strong growth persists despite Medicare fears. Kalia said commentary indicated relatively muted effect on... More

Intersect ENT (XENT) Tops Q1 EPS by 2c

May 2, 2017 4:14 PM EDT

Intersect ENT (NASDAQ: XENT) reported Q1 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $19.38 million.

GUIDANCE:

Intersect ENT sees Q2 2017 revenue of $22.5-22.7 million, versus the... More